logo

Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment

Sector: Government • Location: United States of America

Source: Grants.gov

Project
Archived

Chronic hepatitis B and C represent a major health problem for the United States. Approximately 3.2 million Americans are chronically infected with hepatitis C virus and 1.25 million with chronic hepatitis B virus, with an estimated 55,000 hepatitis C virus- related deaths and 2,000-4,000 hepatitis B related deaths each year. Data from longitudinal cohorts of patients with chronic hepatitis B an

Project Information FAQ

Project Information

5 Q
The project “Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment” is an infrastructure initiative in the Government sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

archived

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

Chronic hepatitis B and C represent a major health problem for the United States. Approximately 3.2 million Americans are chronically infected with hepatitis C virus and 1.25 million with chronic hepatitis B virus, with an estimated 55,000 hepatitis C virus- related deaths and 2,000-4,000 hepatitis B related deaths each year. Data from longitudinal cohorts of patients with chronic hepatitis B and C virus infection are needed to understand the spectrum of disease, the natural history, and the public health impact of chronic viral hepatitis. The purpose of this cooperative agreement is to understand the effectiveness, cost, benefits, and adverse effects of evolving antiviral therapy for hepatitis B virus infection and hepatitis C virus infection on a population basis.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data